Komori
COSMOS Pharmaceutical (3349) · FactExecutive Structure and Responsibilities Updated

Director Retirements and Changes in Responsibilities

First written in FY2018-Q3. 1 of 8 entries say "Advanced", first in 2026-08-03. Latest entry: FY2026.

8entries
9years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q3 – FY20252018: 120182019: 020192020: 020202021: 120212022: 120222023: 120232024: 020242025: 120252026: 32026
Same theme, other companies
Director Departures and Changes in Responsibilities and PositionsA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026Executive Structure and Responsibilities UpdatedAnnual report

    「February 2026 Director and General Manager of the Legal Department of the Company (current) February 2026 Director and General Manager of the Finance and Accounting Department of the Company (current)」

    The position structure is described as Shibata Futoshi (柴田太) becoming Director and General Manager of the Legal Department and Uno Fumihiro (宇野史泰) becoming Director and General Manager of the Finance and Accounting Department.
  2. FY2025Board Composition UpdatedAnnual report

    「August 2025 Director and General Manager of the Merchandise Department of the Company (current) Uno Yoshitaka (宇野 之崇) retired at the conclusion of the General Meeting of Shareholders held on 21 August 2025.」

    Uno Fumihiro (宇野史泰) became Director and General Manager of the Merchandise Department in August 2025, and Uno Yoshitaka (宇野之崇) retired at the conclusion of the General Meeting of Shareholders held in the same month.
  3. FY2023Board Composition UpdatedAnnual report

    「August 2023 Executive Officer and General Manager of the Product Development Department of the Company August 2023 Director and General Manager of the Product Development Department of the Company (current)」

    For Uno Yoshitaka (宇野之崇), the position structure was described as changing from Executive Officer and General Manager of the Product Development Department to Director and General Manager of the Product Development Department.
  4. FY2022Change in Audit and Supervisory Committee MembersAnnual report

    「August 2022 Our company’s Director and Audit and Supervisory Committee Member (currently in office)」

    Watanabe Yuki (渡部有紀) became a director serving as an Audit and Supervisory Committee member in August 2022. The composition of the outside directors serving as Audit and Supervisory Committee members was updated.
  5. FY2021Change in Audit and Supervisory Committee MembersAnnual report

    「August 2021 Our company’s Director and Audit and Supervisory Committee Member (currently in office)」

    Harada Chiyoko (原田知代子) became a Director and Audit and Supervisory Committee Member, and former outside Director and Audit and Supervisory Committee Member Kino Tetsuo (木野哲男) retired.
  6. FY2018-Q3First statedAnnual report

    「Following the submission date of the securities report for the previous fiscal year, the following changes in officers occurred during the current cumulative quarter: (1) Retiring officer: Director and General Manager of the Distribution Department Kawasaki Yoshikazu (川崎 儀和), 18 January 2018. (2) Change in position: Director and General Manager of the Product Development Department; former position: Director and General Manager of the Sales Planning Department; name: Uno Yukitaka (宇野 之崇); effective date: 22 January 2018.」

    Kawasaki Yoshikazu (川崎 儀和) retired as a director on 18 January 2018, and Uno Yukitaka (宇野 之崇) changed from general manager of the Sales Planning Department to general manager of the Product Development Department on 22 January 2018.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for COSMOS Pharmaceutical yet. It last moved in the General Meetings of Shareholders of 2026-08-04: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.